OTC Medicines

Browse OTC Medicines Content

FDA Announcement of a proposed safety-based Administrative Order to update the pregnancy warning labeling for NSAID-containing drug products.

CHPA opposes state and local government attempts to restrict the use of FDA-approved color additives as doing so is vital for maintaining a cohesive regulatory framework.

The Health In Hand Foundation’s mobile-friendly website, HealthInHand.org, provides consumers with easily accessible information and guidance on how to safely use, store, and dispose of self-care products.

CHPA has concerns with granting unilateral authority to temporarily schedule substance restrictions, without legislative oversight or consent

CHPA generally supports prohibitions on animal testing while allowing exemptions in select research areas deemed critical to substantiating human health and safety based on federal or state regulator evaluations.

The OTC Pain Reliever Education Campaign educates consumers on how to appropriately select and safely use OTC internal analgesics.

Current good manufacturing practices establish uniform standards to ensure quality throughout the manufacturing, packaging, labeling, and holding of OTC medicines and dietary supplement products.

Filter Results